NCT05406765View on ClinicalTrials.gov

Enhanced Recovery After Laparoscopic Colorectal Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

October 7, 2022

Study Completion Date

October 7, 2022

Conditions
Rectal CancerPostoperative Pain
Interventions
DRUG

Bupivacaine Injection

One group will receive bupivacaine 15 mg and morphine 100 ug intrathecally

Trial Locations (1)

9038

University Hospital of North Norway, Tromsø

All Listed Sponsors
lead

University Hospital of North Norway

OTHER

NCT05406765 - Enhanced Recovery After Laparoscopic Colorectal Surgery | Biotech Hunter | Biotech Hunter